At Complete Phase, we deliver comprehensive clinical trial biometrics services to support every stage of your study—from early-phase feasibility through final CSR submission.
As your dedicated clinical trial partner, we integrate biostatistics, clinical data management, statistical programming, and pharmacokinetics into an end-to-end biometrics support model. Our agile, TGA-compliant data analytics and reporting workflows ensure robust, audit-ready deliverables that meet the needs of regulatory authorities worldwide.
Our Biostatistics team engages from protocol design through finalisation of the statistical analysis plan (SAP) and clinical study report (CSR). We provide sample size and power calculations, interim and adaptive design simulations, and robust inferential modeling to guide go/no-go decisions. Rapid turn-around statistical programming and audit-ready outputs deliver clear, data-driven insights for your oncology, CNS, and immunology trials.
Through seamless eCRF design and validation, proactive data cleaning & query management, and database lock readiness, our Clinical Data Management experts ensure your trial data is optimally powered and regulatory-compliant. We build integrated databases with real-time oversight, quality-control reviews, and archival processes that satisfy FDA, TGA, and global health authority requirements—so you can trust your data at every milestone.
Our Statistical Programming group specializes in SAS- and R-based generation of tables, listings, and figures (TLFs) compliant with CDISC standards. We develop programmable macros, validate code, and automate CSR-ready outputs to accelerate report production. Whether delivering interim analyses or final TFL packages, we guarantee rapid turn-around, reproducibility, and seamless submission readiness for regulatory dossiers.
Leverage our pharmacokinetics services—ranging from non-compartmental analysis (NCA) and population PK/PD modeling to dose-exposure relationship simulations. We characterize absorption, distribution, metabolism, and excretion (ADME) properties with precision, informing dose selection, drug-drug interaction assessments, and patient diversity considerations. Our integrated PK reports support informed clinical decision-making and regulatory submissions.
With over 50 years of collective experience in Oncology and CNS clinical trials Australia, Complete Phase combines deep scientific insight with agile execution. As your trusted clinical trial partner, we embed proactive communication, tailored resourcing models, and veteran leadership into every biometrics engagement. From initial study concept through regulatory submission, our collaborative approach ensures rigorous safety monitoring, data integrity, and scientific excellence.
Explore our other areas of expertise, including Clinical Operations, Medical Affairs, Pharmacovigilance, and Local Representative services, to streamline your Phase 1 & Phase 2 clinical trials in Australia & New Zealand.
Ready to elevate your biometrics strategy?